{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:30:46Z","timestamp":1788982246131,"version":"build-2803163510"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"DOI":"10.1038\/s41392-026-02622-7","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T11:16:20Z","timestamp":1775042180000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Glucocorticoids elevate clear cell renal cell carcinoma sensitivity to HIF-2\u03b1 inhibitors by suppressing H4K12 lactylation"],"prefix":"10.1038","volume":"11","author":[{"given":"Kenan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zedan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoya","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudun","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiya","family":"Suo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanze","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingcheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5050-7625","authenticated-orcid":false,"given":"Yongfeng","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6595-8995","authenticated-orcid":false,"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7195-677X","authenticated-orcid":false,"given":"Kan","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3917-473X","authenticated-orcid":false,"given":"Luyang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"2622_CR1","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394\u2013424 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"2622_CR2","first-page":"115","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen, W. et al. Cancer statistics in China, 2015. CA Cancer J. Clin. 66, 115\u2013132 (2016).","journal-title":"CA Cancer J. Clin."},{"key":"2622_CR3","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/s41422-018-0079-6","volume":"28","author":"L He","year":"2018","unstructured":"He, L. et al. Imbalance of the reciprocally inhibitory loop between the ubiquitin-specific protease USP43 and EGFR\/PI3K\/AKT drives breast carcinogenesis. Cell Res. 28, 934\u2013951 (2018).","journal-title":"Cell Res."},{"key":"2622_CR4","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/his.13749","volume":"74","author":"AA Batavia","year":"2019","unstructured":"Batavia, A. A., Schraml, P. & Moch, H. Clear cell renal cell carcinoma with wild-type von Hippel-Lindau gene: A non-existent or new tumour entity?. Histopathology 74, 60\u201367 (2019).","journal-title":"Histopathology"},{"key":"2622_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nrc3844","volume":"15","author":"L Gossage","year":"2015","unstructured":"Gossage, L., Eisen, T. & Maher, E. R. VHL, the story of a tumour suppressor gene. Nat. Rev. Cancer 15, 55\u201364 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"2622_CR6","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/s41591-021-01324-7","volume":"27","author":"TK Choueiri","year":"2021","unstructured":"Choueiri, T. K. et al. Inhibition of hypoxia-inducible factor-2alpha in renal cell carcinoma with belzutifan: a phase 1 trial and biomarker analysis. Nat. Med. 27, 802\u2013805 (2021).","journal-title":"Nat. Med."},{"key":"2622_CR7","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S1470-2045(23)00097-9","volume":"24","author":"TK Choueiri","year":"2023","unstructured":"Choueiri, T. K. et al. Belzutifan plus cabozantinib for patients with advanced clear cell renal cell carcinoma previously treated with immunotherapy: an open-label, single-arm, phase 2 study. Lancet Oncol. 24, 553\u2013562 (2023).","journal-title":"Lancet Oncol."},{"key":"2622_CR8","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nature13557","volume":"513","author":"B Li","year":"2014","unstructured":"Li, B. et al. Fructose-1,6-bisphosphatase opposes renal carcinoma progression. Nature 513, 251\u2013255 (2014).","journal-title":"Nature"},{"key":"2622_CR9","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.eururo.2015.09.014","volume":"69","author":"A Kinnaird","year":"2016","unstructured":"Kinnaird, A. et al. Metabolic modulation of clear-cell renal cell carcinoma with dichloroacetate, an inhibitor of pyruvate dehydrogenase kinase. Eur. Urol. 69, 734\u2013744 (2016).","journal-title":"Eur. Urol."},{"key":"2622_CR10","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.semcancer.2020.07.015","volume":"83","author":"ME Neganova","year":"2022","unstructured":"Neganova, M. E., Klochkov, S. G., Aleksandrova, Y. R. & Aliev, G. Histone modifications in epigenetic regulation of cancer: perspectives and achieved progress. Semin. Cancer Biol. 83, 452\u2013471 (2022).","journal-title":"Semin. Cancer Biol."},{"key":"2622_CR11","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang, D. et al. Metabolic regulation of gene expression by histone lactylation. Nature 574, 575\u2013580 (2019).","journal-title":"Nature"},{"key":"2622_CR12","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.cmet.2022.02.013","volume":"34","author":"RY Pan","year":"2022","unstructured":"Pan, R. Y. et al. Positive feedback regulation of microglial glucose metabolism by histone H4 lysine 12 lactylation in Alzheimer\u2019s disease. Cell Metab. 34, 634\u2013648 e636 (2022).","journal-title":"Cell Metab."},{"key":"2622_CR13","doi-asserted-by":"publisher","first-page":"e174587","DOI":"10.1172\/JCI174587","volume":"134","author":"J Ju","year":"2024","unstructured":"Ju, J. et al. The alanyl-tRNA synthetase AARS1 moonlights as a lactyltransferase to promote YAP signaling in gastric cancer. J. Clin. Invest. 134, e174587 (2024).","journal-title":"J. Clin. Invest."},{"key":"2622_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41422-023-00864-6","volume":"34","author":"Y Mao","year":"2024","unstructured":"Mao, Y. et al. Hypoxia induces mitochondrial protein lactylation to limit oxidative phosphorylation. Cell Res. 34, 13\u201330 (2024).","journal-title":"Cell Res."},{"key":"2622_CR15","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cmet.2022.01.007","volume":"34","author":"NN Pavlova","year":"2022","unstructured":"Pavlova, N. N., Zhu, J. & Thompson, C. B. The hallmarks of cancer metabolism: still emerging. Cell Metab. 34, 355\u2013377 (2022).","journal-title":"Cell Metab."},{"key":"2622_CR16","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41568-021-00357-x","volume":"21","author":"S Zhao","year":"2021","unstructured":"Zhao, S., Allis, C. D. & Wang, G. G. The language of chromatin modification in human cancers. Nat. Rev. Cancer 21, 413\u2013430 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"2622_CR17","doi-asserted-by":"publisher","first-page":"3470","DOI":"10.7150\/ijbs.73398","volume":"18","author":"J Yang","year":"2022","unstructured":"Yang, J. et al. A positive feedback loop between inactive VHL-triggered histone lactylation and PDGFRbeta signaling drives clear cell renal cell carcinoma progression. Int. J. Biol. Sci. 18, 3470\u20133483 (2022).","journal-title":"Int. J. Biol. Sci."},{"key":"2622_CR18","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1038\/s41586-022-04809-8","volume":"606","author":"SA Patel","year":"2022","unstructured":"Patel, S. A. et al. The renal lineage factor PAX8 controls oncogenic signalling in kidney cancer. Nature 606, 999\u20131006 (2022).","journal-title":"Nature"},{"key":"2622_CR19","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1007\/s00345-018-2288-5","volume":"36","author":"ER Maher","year":"2018","unstructured":"Maher, E. R. Hereditary renal cell carcinoma syndromes: diagnosis, surveillance and management. World J. Urol. 36, 1891\u20131898 (2018).","journal-title":"World J. Urol."},{"key":"2622_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15337","volume":"8","author":"YH Gao","year":"2017","unstructured":"Gao, Y. H. et al. VHL deficiency augments anthracycline sensitivity of clear cell renal cell carcinomas by down-regulating ALDH2. Nat. Commun. 8, 15337 (2017).","journal-title":"Nat. Commun."},{"key":"2622_CR21","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.molcel.2020.01.009","volume":"77","author":"X Liu","year":"2020","unstructured":"Liu, X. et al. Genome-wide screening identifies SFMBT1 as an oncogenic driver in cancer with VHL loss. Mol. Cell 77, 1294\u20131306.e1295 (2020).","journal-title":"Mol. Cell"},{"key":"2622_CR22","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1158\/2159-8290.CD-11-0098","volume":"1","author":"C Shen","year":"2011","unstructured":"Shen, C. et al. Genetic and functional studies implicate HIF1alpha as a 14q kidney cancer suppressor gene. Cancer Discov. 1, 222\u2013235 (2011).","journal-title":"Cancer Discov."},{"key":"2622_CR23","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1038\/s41591-018-0194-4","volume":"24","author":"C Qiu","year":"2018","unstructured":"Qiu, C. et al. Renal compartment-specific genetic variation analyses identify new pathways in chronic kidney disease. Nat. Med. 24, 1721\u20131731 (2018).","journal-title":"Nat. Med."},{"key":"2622_CR24","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/cac2.12428","volume":"43","author":"L Luo","year":"2023","unstructured":"Luo, L. et al. MFN2 suppresses clear cell renal cell carcinoma progression by modulating mitochondria-dependent dephosphorylation of EGFR. Cancer Commun. 43, 808\u2013833 (2023).","journal-title":"Cancer Commun."},{"key":"2622_CR25","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1126\/science.aap8411","volume":"361","author":"J Zhang","year":"2018","unstructured":"Zhang, J. et al. VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma. Science 361, 290\u2013295 (2018).","journal-title":"Science"},{"key":"2622_CR26","first-page":"2515","volume":"7","author":"G Liu","year":"2017","unstructured":"Liu, G., Ye, Z., Zhao, X. & Ji, Z. SP1-induced up-regulation of lncRNA SNHG14 as a ceRNA promotes migration and invasion of clear cell renal cell carcinoma by regulating N-WASP. Am. J. Cancer Res. 7, 2515\u20132525 (2017).","journal-title":"Am. J. Cancer Res."},{"key":"2622_CR27","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41581-020-00359-2","volume":"17","author":"E Jonasch","year":"2021","unstructured":"Jonasch, E., Walker, C. L. & Rathmell, W. K. Clear cell renal cell carcinoma ontogeny and mechanisms of lethality. Nat. Rev. Nephrol. 17, 245\u2013261 (2021).","journal-title":"Nat. Rev. Nephrol."},{"key":"2622_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11672-1","volume":"10","author":"M Bleu","year":"2019","unstructured":"Bleu, M. et al. PAX8 activates metabolic genes via enhancer elements in Renal Cell Carcinoma. Nat. Commun. 10, 3739 (2019).","journal-title":"Nat. Commun."},{"key":"2622_CR29","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1111\/his.14076","volume":"76","author":"JY Park","year":"2020","unstructured":"Park, J. Y. et al. FGFR1 is associated with c-MYC and proangiogenic molecules in metastatic renal cell carcinoma under anti-angiogenic therapy. Histopathology 76, 838\u2013851 (2020).","journal-title":"Histopathology"},{"key":"2622_CR30","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1158\/2159-8290.CD-17-0375","volume":"7","author":"X Yao","year":"2017","unstructured":"Yao, X. et al. VHL deficiency drives enhancer activation of oncogenes in clear cell renal cell carcinoma. Cancer Discov. 7, 1284\u20131305 (2017).","journal-title":"Cancer Discov."},{"key":"2622_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13601-8","volume":"11","author":"H Nie","year":"2020","unstructured":"Nie, H. et al. O-GlcNAcylation of PGK1 coordinates glycolysis and TCA cycle to promote tumor growth. Nat. Commun. 11, 36 (2020).","journal-title":"Nat. Commun."},{"key":"2622_CR32","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41392-020-00222-7","volume":"5","author":"Y Xie","year":"2020","unstructured":"Xie, Y. et al. FGF\/FGFR signaling in health and disease. Signal Transduct. Target Ther. 5, 181 (2020).","journal-title":"Signal Transduct. Target Ther."},{"key":"2622_CR33","first-page":"4312","volume":"12","author":"F Xiao","year":"2022","unstructured":"Xiao, F. et al. ZNF395 facilitates macrophage polarization and impacts the prognosis of glioma. Am. J. Cancer Res. 12, 4312\u20134325 (2022).","journal-title":"Am. J. Cancer Res."},{"key":"2622_CR34","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/S0021-9258(18)98146-9","volume":"234","author":"WB Novoa","year":"1959","unstructured":"Novoa, W. B., Winer, A. D., Glaid, A. J. & Schwert, G. W. Lactic dehydrogenase. V. Inhibition by oxamate and by oxalate. J. Biol. Chem. 234, 1143\u20131148 (1959).","journal-title":"J. Biol. Chem."},{"key":"2622_CR35","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ccell.2020.01.001","volume":"37","author":"J Jiang","year":"2020","unstructured":"Jiang, J. et al. Direct phosphorylation and stabilization of MYC by Aurora B kinase promote T-cell leukemogenesis. Cancer Cell 37, 200\u2013215.e205 (2020).","journal-title":"Cancer Cell"},{"key":"2622_CR36","doi-asserted-by":"publisher","first-page":"10539","DOI":"10.1093\/nar\/gkw742","volume":"44","author":"D Ratman","year":"2016","unstructured":"Ratman, D. et al. Chromatin recruitment of activated AMPK drives fasting response genes co-controlled by GR and PPARalpha. Nucleic Acids Res. 44, 10539\u201310553 (2016).","journal-title":"Nucleic Acids Res."},{"key":"2622_CR37","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nrm.2016.152","volume":"18","author":"ER Weikum","year":"2017","unstructured":"Weikum, E. R., Knuesel, M. T., Ortlund, E. A. & Yamamoto, K. R. Glucocorticoid receptor control of transcription: precision and plasticity via allostery. Nat. Rev. Mol. Cell Biol. 18, 159\u2013174 (2017).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2622_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-13-101","volume":"13","author":"H Girgis","year":"2014","unstructured":"Girgis, H. et al. Lactate dehydrogenase A is a potential prognostic marker in clear cell renal cell carcinoma. Mol. Cancer 13, 101 (2014).","journal-title":"Mol. Cancer"},{"key":"2622_CR39","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3389\/fphar.2019.00308","volume":"10","author":"O Bereshchenko","year":"2019","unstructured":"Bereshchenko, O., Migliorati, G., Bruscoli, S. & Riccardi, C. Glucocorticoid-induced leucine zipper: a novel anti-inflammatory molecule. Front. Pharmacol. 10, 308 (2019).","journal-title":"Front. Pharmacol."},{"key":"2622_CR40","doi-asserted-by":"publisher","first-page":"8393","DOI":"10.1093\/nar\/gkaa565","volume":"48","author":"L Escoter-Torres","year":"2020","unstructured":"Escoter-Torres, L., Greulich, F., Quagliarini, F., Wierer, M. & Uhlenhaut, N. H. Anti-inflammatory functions of the glucocorticoid receptor require DNA binding. Nucleic Acids Res. 48, 8393\u20138407 (2020).","journal-title":"Nucleic Acids Res."},{"key":"2622_CR41","doi-asserted-by":"publisher","first-page":"bqac150","DOI":"10.1210\/endocr\/bqac150","volume":"163","author":"NC Nicolaides","year":"2022","unstructured":"Nicolaides, N. C. The human glucocorticoid receptor beta: from molecular mechanisms to clinical implications. Endocrinology 163, bqac150 (2022).","journal-title":"Endocrinology"},{"key":"2622_CR42","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41586-024-07282-7","volume":"629","author":"JP Auger","year":"2024","unstructured":"Auger, J. P. et al. Metabolic rewiring promotes anti-inflammatory effects of glucocorticoids. Nature 629, 184\u2013192 (2024).","journal-title":"Nature"},{"key":"2622_CR43","first-page":"1","volume":"45","author":"RM Evans","year":"1989","unstructured":"Evans, R. M. Molecular characterization of the glucocorticoid receptor. Recent Prog. Horm. Res. 45, 1\u201322 (1989).","journal-title":"Recent Prog. Horm. Res."},{"key":"2622_CR44","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/0092-8674(88)90145-6","volume":"55","author":"SM Hollenberg","year":"1988","unstructured":"Hollenberg, S. M. & Evans, R. M. Multiple and cooperative trans-activation domains of the human glucocorticoid receptor. Cell 55, 899\u2013906 (1988).","journal-title":"Cell"},{"key":"2622_CR45","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/0092-8674(86)90339-9","volume":"46","author":"V Giguere","year":"1986","unstructured":"Giguere, V., Hollenberg, S. M., Rosenfeld, M. G. & Evans, R. M. Functional domains of the human glucocorticoid receptor. Cell 46, 645\u2013652 (1986).","journal-title":"Cell"},{"key":"2622_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08616-8","volume":"21","author":"E Arnaiz","year":"2021","unstructured":"Arnaiz, E. et al. Differential effects of HIF2alpha antagonist and HIF2alpha silencing in renal cancer and sensitivity to repurposed drugs. BMC Cancer 21, 896 (2021).","journal-title":"BMC Cancer"},{"key":"2622_CR47","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1038\/s41388-023-02666-x","volume":"42","author":"J Lu","year":"2023","unstructured":"Lu, J. et al. LZTFL1 inhibits kidney tumor cell growth by destabilizing AKT through ZNRF1-mediated ubiquitin proteosome pathway. Oncogene 42, 1543\u20131557 (2023).","journal-title":"Oncogene"},{"key":"2622_CR48","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/s41392-022-01151-3","volume":"7","author":"X Li","year":"2022","unstructured":"Li, X. et al. Lactate metabolism in human health and disease. Signal Transduct. Target Ther. 7, 305 (2022).","journal-title":"Signal Transduct. Target Ther."},{"key":"2622_CR49","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.cell.2017.09.019","volume":"171","author":"B Faubert","year":"2017","unstructured":"Faubert, B. et al. Lactate metabolism in human lung tumors. Cell 171, 358\u2013371.e359 (2017).","journal-title":"Cell"},{"key":"2622_CR50","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1038\/s42255-020-0267-9","volume":"2","author":"L Li","year":"2020","unstructured":"Li, L. et al. Glis1 facilitates induction of pluripotency via an epigenome-metabolome-epigenome signalling cascade. Nat. Metab. 2, 882\u2013892 (2020).","journal-title":"Nat. Metab."},{"key":"2622_CR51","doi-asserted-by":"publisher","first-page":"786666","DOI":"10.3389\/fimmu.2021.786666","volume":"12","author":"X Chu","year":"2021","unstructured":"Chu, X. et al. Lactylated histone H3K18 as a potential biomarker for the diagnosis and predicting the severity of septic shock. Front. Immunol. 12, 786666 (2021).","journal-title":"Front. Immunol."},{"key":"2622_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-021-02308-z","volume":"22","author":"J Yu","year":"2021","unstructured":"Yu, J. et al. Histone lactylation drives oncogenesis by facilitating m(6)A reader protein YTHDF2 expression in ocular melanoma. Genome Biol. 22, 85 (2021).","journal-title":"Genome Biol."},{"key":"2622_CR53","doi-asserted-by":"publisher","first-page":"647559","DOI":"10.3389\/fonc.2021.647559","volume":"11","author":"J Jiang","year":"2021","unstructured":"Jiang, J. et al. Lactate modulates cellular metabolism through histone lactylation-mediated gene expression in non-small cell lung cancer. Front. Oncol. 11, 647559 (2021).","journal-title":"Front. Oncol."},{"key":"2622_CR54","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S0168-9525(98)01558-3","volume":"14","author":"WG Kaelin Jr.","year":"1998","unstructured":"Kaelin, W. G. Jr. & Maher, E. R. The VHL tumour-suppressor gene paradigm. Trends Genet. 14, 423\u2013426 (1998).","journal-title":"Trends Genet."},{"key":"2622_CR55","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1165\/rcmb.2020-0360OC","volume":"64","author":"H Cui","year":"2021","unstructured":"Cui, H. et al. Lung myofibroblasts promote macrophage profibrotic activity through lactate-induced histone lactylation. Am. J. Respir. Cell Mol. Biol. 64, 115\u2013125 (2021).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"2622_CR56","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s42255-022-00710-w","volume":"5","author":"Z Yang","year":"2023","unstructured":"Yang, Z. et al. Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma. Nat. Metab. 5, 61\u201379 (2023).","journal-title":"Nat. Metab."},{"key":"2622_CR57","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.cell.2016.07.049","volume":"166","author":"CM Vockley","year":"2016","unstructured":"Vockley, C. M. et al. Direct GR binding sites potentiate clusters of TF binding across the human genome. Cell 166, 1269\u20131281.e1219 (2016).","journal-title":"Cell"},{"key":"2622_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.toxlet.2022.05.003","volume":"363","author":"M Chen","year":"2022","unstructured":"Chen, M. et al. Upregulation of hepatic CD36 via glucocorticoid receptor activation contributes to dexamethasone-induced liver lipid metabolism disorder in mice. Toxicol. Lett. 363, 1\u201310 (2022).","journal-title":"Toxicol. Lett."},{"key":"2622_CR59","doi-asserted-by":"publisher","first-page":"M133","DOI":"10.1530\/EJE-15-0354","volume":"173","author":"F Ferrau","year":"2015","unstructured":"Ferrau, F. & Korbonits, M. Metabolic comorbidities in Cushing\u2019s syndrome. Eur. J. Endocrinol. 173, M133\u2013M157 (2015).","journal-title":"Eur. J. Endocrinol."},{"key":"2622_CR60","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41586-024-07620-9","volume":"631","author":"H Chen","year":"2024","unstructured":"Chen, H. et al. NBS1 lactylation is required for efficient DNA repair and chemotherapy resistance. Nature 631, 663\u2013669 (2024).","journal-title":"Nature"},{"key":"2622_CR61","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.ejphar.2011.02.043","volume":"658","author":"L Lu","year":"2011","unstructured":"Lu, L. et al. Shikonin extracted from medicinal Chinese herbs exerts anti-inflammatory effect via proteasome inhibition. Eur. J. Pharmacol. 658, 242\u2013247 (2011).","journal-title":"Eur. J. Pharmacol."},{"key":"2622_CR62","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/nm.4343","volume":"23","author":"S Harlander","year":"2017","unstructured":"Harlander, S. et al. Combined mutation in Vhl, Trp53 and Rb1 causes clear cell renal cell carcinoma in mice. Nat. Med. 23, 869\u2013877 (2017).","journal-title":"Nat. Med."},{"key":"2622_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09982-5","volume":"10","author":"HS Kaya-Okur","year":"2019","unstructured":"Kaya-Okur, H. S. et al. CUT&Tag for efficient epigenomic profiling of small samples and single cells. Nat. Commun. 10, 1930 (2019).","journal-title":"Nat. Commun."},{"key":"2622_CR64","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1158\/2159-8290.CD-19-0837","volume":"10","author":"L Hu","year":"2020","unstructured":"Hu, L. et al. TBK1 is a synthetic lethal target in cancer with VHL loss. Cancer Discov. 10, 460\u2013475 (2020).","journal-title":"Cancer Discov."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02622-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02622-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02622-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T12:05:34Z","timestamp":1775045134000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02622-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2622"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02622-7","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"30 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"117"}}